Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LPAR3 | Q9UBY5 | 7/20 | 0.71 |
| ▸ | LPAR1 | Q92633 | 6/20 | 0.71 |
| ▸ | LPAR5 | Q9H1C0 | 1/20 | 0.53 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.52 |
| ▸ | S1PR2 | O95136 | 3/20 | 0.49 |
| ▸ | S1PR1 | P21453 | 3/20 | 0.49 |
| ▸ | S1PR3 | Q99500 | 3/20 | 0.49 |
| ▸ | S1PR5 | Q9H228 | 1/20 | 0.49 |
| ▸ | ENPP2 | Q13822 | 5/20 | 0.46 |
| ▸ | TLR2 | O60603 | 3/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.45 |
| ▸ | P2RY10 | O00398 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL370759 | 0.85 | LPAR3 (0.97) | LPAR3LPAR1LPAR5LPAR2ENPP2 | |
| SCHEMBL2732573 | 0.85 | LPAR3 (0.97) | LPAR3LPAR1LPAR5LPAR2ENPP2 | |
| SCHEMBL5055004 | 0.83 | LPAR3 (1.00) | LPAR3LPAR1LPAR5LPAR2ENPP2 | |
| SCHEMBL2814732 | 0.83 | LPAR3 (1.00) | LPAR3LPAR1LPAR5LPAR2ENPP2 | |
| SCHEMBL31198159 | 0.83 | LPAR3 (1.00) | LPAR3LPAR1LPAR5LPAR2ENPP2 | |
| SCHEMBL2813163 | 0.83 | LPAR3 (1.00) | LPAR3LPAR1LPAR5LPAR2ENPP2 | |
| SCHEMBL496845 | 0.83 | LPAR3 (1.00) | LPAR3LPAR1LPAR5LPAR2ENPP2 | |
| SCHEMBL31439420 | 0.83 | LPAR3 (1.00) | LPAR3LPAR1LPAR5LPAR2ENPP2 | |
| SCHEMBL10896195 | 0.83 | LPAR3 (1.00) | LPAR3LPAR1LPAR5LPAR2ENPP2 | |
| SCHEMBL29458233 | 0.83 | LPAR3 (1.00) | LPAR3LPAR1LPAR5LPAR2ENPP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0119056-B1 | SURFACTANT COMPOSITION AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME FOR USE IN THE TREATMENT OF RESPIRATORY DISTRESS SYNDROME | TOKYO TANABE COMPANY LIMITED (JP) | 1990-08-29 | — | — | EP | claimed |
| US-4603124-A | FILM-FORMING MIXTURE OF CHOLINE PHOSPHO GLYCERIDE, ACID PHOSPHOLIPID, FATTY ACID, AND LIPOPROTEIN | TOKYO TANABE COMPANY, LIMITED (JP) | 1986-07-29 | — | — | US | claimed |
| EP-0119056-A2 | Surfactant composition and pharmaceutical compositions containing same for use in the treatment of respiratory distress syndrome | TOKYO TANABE COMPANY LIMITED (JP) | 1984-09-19 | — | — | EP | claimed |
| EP-0935139-B1 | IMMUNOHISTOCHEMICAL STAINING COMPOSITION | DAIICHI PURE CHEMICALS CO LTD (JP) | 2004-11-17 | — | — | EP | disclosed |
| EP-0733645-B1 | NOVEL SYNTHETIC PEPTIDE, LUNG SURFACTANT CONTAINING THE SAME, AND REMEDY FOR RESPIRATORY DISTRESS SYNDROME | MITSUBISHI PHARMA CORP (JP) | 2003-03-19 | — | — | EP | disclosed |
| US-20020028474-A1 | Composition for immunohistochemical staining | DAIICHI PURE CHEMICAL CO., LTD. (JP) | 2002-03-07 | — | — | US | disclosed |
| US-6042622-A | Process for crystallization of alkali metal bicarbonate salts | BASF CORPORATION (US) | 2000-03-28 | — | — | US | disclosed |
| EP-0935139-A1 | IMMUNOHISTOCHEMICAL STAINING COMPOSITION | DAIICHI PURE CHEMICALS CO., LTD. (JP) | 1999-08-11 | — | — | EP | disclosed |
| US-5827825-A | POLYPEPTIDE FROM THE CONDENSATION OF VARIABLE HEXA- OR HEPTAPEPTIDES WITH PEPTIDES CONTAINING TWELVE TO TWENTY UNITS OF LEUCINE AND/OR NORLEUCINE, FOR TREATMENT OF RESPIRATORY DISORDERS | TOKYO TANABE COMPANY LTD. (JP) | 1998-10-27 | — | — | US | disclosed |
| US-5716419-A | Process for crystallization of mineral salts | PPG INDUSTRIES, INC. (US) | 1998-02-10 | — | — | US | disclosed |
| EP-0733645-A1 | NOVEL SYNTHETIC PEPTIDE, LUNG SURFACTANT CONTAINING THE SAME, AND REMEDY FOR RESPIRATORY DISTRESS SYNDROME | TOKYO TANABE COMPANY LIMITED (JP) | 1996-09-25 | — | — | EP | disclosed |
| EP-0652011-A1 | PROPHYLACTIC AND REMEDY FOR VIRAL DISEASES IN RESPIRATORY TRACT | TOKYO TANABE COMPANY LIMITED (JP) | 1995-05-10 | — | — | EP | disclosed |
| EP-0119056-B1 | SURFACTANT COMPOSITION AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME FOR USE IN THE TREATMENT OF RESPIRATORY DISTRESS SYNDROME | TOKYO TANABE COMPANY LIMITED (JP) | 1990-08-29 | — | — | EP | disclosed |
| US-4603124-A | FILM-FORMING MIXTURE OF CHOLINE PHOSPHO GLYCERIDE, ACID PHOSPHOLIPID, FATTY ACID, AND LIPOPROTEIN | TOKYO TANABE COMPANY, LIMITED (JP) | 1986-07-29 | — | — | US | disclosed |
| EP-0119056-A2 | Surfactant composition and pharmaceutical compositions containing same for use in the treatment of respiratory distress syndrome | TOKYO TANABE COMPANY LIMITED (JP) | 1984-09-19 | — | — | EP | disclosed |